Palvella Therapeutics COO Kathleen Goin disposes of 4,302 common shares worth $642,194.57
PVLA•COO sells shares after exercising options
Palvella Therapeutics COO Kathleen Goin sold 4,302 common shares on July 15, 2026, cutting her direct stake to zero.
The sales were priced at $147.14 to $150.25 per share, on a weighted-average basis across multiple trades.
She exercised stock options for 4,302 shares the same day at $7.14 to $9.08 per share.
